| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.08 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |